These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 16931889)
1. Saliva secretion in patients with allergic rhinitis. Elad S; Heisler S; Shalit M Int Arch Allergy Immunol; 2006; 141(3):276-80. PubMed ID: 16931889 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468 [TBL] [Abstract][Full Text] [Related]
3. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine. Glass DJ; Harper AS BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016 [TBL] [Abstract][Full Text] [Related]
4. A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis. Lee J; Cummins G; Okamoto L Am J Manag Care; 2001 May; 7(4 Suppl):S103-12. PubMed ID: 11392821 [TBL] [Abstract][Full Text] [Related]
5. The costs of nonsedating antihistamine therapy for allergic rhinitis in managed care: an updated analysis. Liao E; Leahy M; Cummins G Am J Manag Care; 2001 Oct; 7(15 Suppl):S459-68. PubMed ID: 11680261 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders. Prenner BM; Capano D; Harris AG Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy. Roongapinun S; Wajajamreon S; Fooanant S J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen. Hyo S; Fujieda S; Kawada R; Kitazawa S; Takenaka H Ann Allergy Asthma Immunol; 2005 Apr; 94(4):457-64. PubMed ID: 15875527 [TBL] [Abstract][Full Text] [Related]
9. Link between patient preferences and treatment outcomes in seasonal allergic rhinitis: an empiric investigation. Ricard N; Kind P; Christian S; Jensen M; Stewart J Clin Ther; 1999 Jan; 21(1):268-77. PubMed ID: 10090440 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies. Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959 [TBL] [Abstract][Full Text] [Related]
11. The effects of an H3 receptor antagonist (PF-03654746) with fexofenadine on reducing allergic rhinitis symptoms. Stokes JR; Romero FA; Allan RJ; Phillips PG; Hackman F; Misfeldt J; Casale TB J Allergy Clin Immunol; 2012 Feb; 129(2):409-12, 412.e1-2. PubMed ID: 22196768 [TBL] [Abstract][Full Text] [Related]
12. [Clinical aspects of anti-inflammatory action of antihistamines]. Grzelewska-Rzymowska I Pol Merkur Lekarski; 2003 Jun; 14(84):634-8. PubMed ID: 14524290 [TBL] [Abstract][Full Text] [Related]
13. A comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of 3- to 6-year-old children with seasonal allergic rhinitis. Lutsky BN; Klöse P; Melon J; Menardo JL; Molkhou P; Ronchetti R; Suonpää J; Wahn U; Wessel F Clin Ther; 1993; 15(5):855-65. PubMed ID: 8269452 [TBL] [Abstract][Full Text] [Related]
14. Comparison of loratadine and terfenadine in allergic seasonal rhinoconjunctivitis with emphasis on nasal stuffiness and peak flow. Olsen OT; Nüchel Petersen L; Høi L; Lorentzen KA; Hindberg Rasmussen W; Svendsen UG Arzneimittelforschung; 1992 Oct; 42(10):1227-31. PubMed ID: 1472143 [TBL] [Abstract][Full Text] [Related]
15. Feeling of dry mouth in relation to whole and minor gland saliva secretion rate. Eliasson L; Birkhed D; Carlén A Arch Oral Biol; 2009 Mar; 54(3):263-7. PubMed ID: 18922513 [TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Grant JA; Riethuisen JM; Moulaert B; DeVos C Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924 [TBL] [Abstract][Full Text] [Related]
17. Assessing patient satisfaction with desloratadine after conversion from loratadine, fexofenadine, or cetirizine. Glass D; Harper A Manag Care Interface; 2004 Feb; 17(2):29-34. PubMed ID: 15038691 [TBL] [Abstract][Full Text] [Related]
18. [Effects of H1 blocker and inhaled corticosteroids on asthmatic patients with allergic rhinitis]. He WQ; Zheng JP; Ran PX; Liu HZ; Lin H; Cai DM; Xu JM; Zhong NS Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):157-60. PubMed ID: 12816681 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. LaForce CF; Corren J; Wheeler WJ; Berger WE; Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675 [TBL] [Abstract][Full Text] [Related]
20. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis. Horak F; Bruttmann G; Pedrali P; Weeke B; Frølund L; Wolff HH; Christophers E Arzneimittelforschung; 1988 Jan; 38(1):124-8. PubMed ID: 2896508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]